MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Screening of posterior cortical dysfunction in early Parkinson’s disease with mild cognitive impairment as an approach to select patients at higher risk for developing dementia

    H. Bejr-Kasem, J. Pagonabarraga, R. Fernandez-Bobadilla, J. Perez-Perez, J. Marin-Lahoz, B. Pascual-Sedano, S. Martínez-Horta, J. Kulisevsky (Barcelona, Spain)

    Objective: Based on the importance of progressive dysfunction of posterior cortical regions in cognitive deterioration in PD, we explored whether posterior cortical dysfunction in early…
  • 2016 International Congress

    Rapid eye movement sleep behavior disorder symptoms correlate with domains of cognitive impairment in Parkinson’s disease

    J.R. Zhang, J. Chen, Z.J. Yang, H.J. Zhang, Y.T. Fu, Y. Shen, P.C. He, C.J. Mao, C.F. Liu (Suzhou, People's Republic of China)

    Objective: To investigate (1) the domains of cognitive impairment in patients with Parkinson's disease (PD) and rapid eye movement sleep behavior disorder (RBD). (2) To…
  • 2016 International Congress

    Dyskinesias-reduced-self-awareness and theory of mind in Parkinson’s disease: A novel frame of interpretation

    S. Palermo, M. Amanzio, M. Zibetti, L. Lopiano (Turin, Italy)

    Objective: To analyze the existence of a relationship between Dyskinesias-reduced-self-awareness (DRSA) and abilities related to cognitive and affective Theory of Mind (ToM), which may represent…
  • 2016 International Congress

    Transcranial sonography and cognitive dysfunction in Parkinson’s disease

    S. Behnke, A. Pilotto, I. Liepelt-Scarfone, R. Yilmaz, C. Pausch, S. Dieterich, I. Posner, J. Spiegel, U. Dillmann, M. Unger, B. Schmidl, J. Bürmann, K. Fassbender, D. Berg (Homburg Saar, Germany)

    Objective: To evaluate the role of transcranial sonography (TCS) in discriminating between Parkinson's disease (PD) patients with normal cognition (PDNC), mild cognitive impairment (PD-MCI) and…
  • 2016 International Congress

    Cognition and amyloid biomarker status in non-demented patients with Parkinson’s disease patients (PD) with or without subjective cognitive decline (SCD)

    I. Liepelt-Scarfone, F. Klumpp, W. Maetzler, S. Nussbaum, M. Timmers, G. Salvadore, M. Albers, K. Michaelis, Z. Tkaczynska, J. Streffer, D. Berg (Tübingen, Germany)

    Objective: To compare the cognitive and Amyloid-beta 1-42 profile of non-demented Parkinson's disease patients (PD) reporting subjective cognitive decline (SCD) with or without concerns regarding…
  • 2016 International Congress

    Construct validity of Moca test in a sample of patients with Parkinson´s disease in Bogotá and Cali – Colombia

    B.E. Muñoz, O. Bernal, A. Castillo, J.L. Orozco (Cali, Colombia)

    Objective: To evaluate of construct validity for a sample of patients with PD in Bogotá and Cali - Colombia. Background: Parkinson´s disease (PD) is a…
  • 2016 International Congress

    Fractionating apathy – Effort, reward and impulsivity mechanisms in Parkinson’s and Huntington’s disease

    C. O'Callaghan, S. Mason, C. Williams-Gray, R. Barker, B. Sahakian, T. Robbins (Cambridge, United Kingdom)

    Objective: Refine understanding of the processes underpinning apathy in neurodegenerative disease, by identifying 1) objective measures to assess apathy; 2) parcellating the broad construct of…
  • 2016 International Congress

    Viewer responses to a virtual reality simulation of Parkinson’s disease psychosis

    J.G. Goldman, G.T. Stebbins, D. Fredericks, M. Upchurch (Chicago, IL, USA)

    Objective: To examine the accuracy, effectiveness, and utility of a novel virtual reality (VR) simulation representing symptoms of Parkinson's disease psychosis (PDP). Background: Diagnosing PDP…
  • 2016 International Congress

    Standardized assessment of camptocormia in idiopathic Parkinson’s disease

    T. Schmidt, G. Ebersbach, G. Doreen (Beelitz-Heilstätten, Germany)

    Objective: The present study aimed to develop a clinical algorithm to comprehensively characterize CC in PD. Background: Clinical assessment of Camptocormia (CC) in Parkinson's disease…
  • 2016 International Congress

    Comparative analysis of upper limb motor function and articulation disorder in Parkinson’s disease

    E. Ruzicka, J. Rusz, T. Tykalova, K. Zarubova, R. Krupicka, R. Jech (Prague, Czech Republic)

    Objective: To assess the relationship between upper limb bradykinesia and hypokinetic dysarthria in Parkinson's disease (PD) using instrumental investigations of speech and limb motor function.…
  • « Previous Page
  • 1
  • …
  • 105
  • 106
  • 107
  • 108
  • 109
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Common mistakes in the MoCA test in patients with Parkinson’s Disease in Kyrgyzstan
  • Clinical Associations of Hand Deformities in Parkinson´s Disease
  • #24970 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley